Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.52
Delayed Data
As of 3:59pm ET
 -0.08 / -5.00%
Today’s Change
1.47
Today|||52-Week Range
14.60
-13.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$152.1M

Company Description

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Contact Information

Adverum Biotechnologies, Inc.
800 Saginaw Drive
Redwood City California 94063
P:(650) 656-9323
Investor Relations:

Employees

Shareholders

Other institutional45.67%
Individual stakeholders4.30%
Mutual fund holders21.26%

Top Executives

Laurent FischerPresident, CEO, Director & Chief Medical Officer
Peter SoparkarChief Operating Officer
Rupert D’SouzaChief Financial & Accounting Officer
Heikki JouttijärviSenior VP & Head-Technical Operations
Brigit RileyChief Scientific Officer